Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance

Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus

November 8, 2018 7:32 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.04 better than the analyst estimate of $0.16. Revenue for the quarter came in at $53.1 million versus the consensus estimate of $51.11 million.

Jack Kenny, Chief Executive Officer, commented, We are pleased to report these very positive fourth quarter and... More